/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

S.M. Keller

Merck & Co., Inc., Rahway, NJ, USA (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

40

Papers

944

Citations

11

h-index

13

i10-index

S.M. Keller is an academic researcher from Merck & Co., Inc., Rahway, NJ, USA (United States). The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers. The author has an h-index of 11, co-authored 34 publications.

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Cancer Immunotherapy and Biomarkers Esophageal Cancer Research and Treatment Gastric Cancer Management and Outcomes

Papers by this author

works

Overcoming the barriers to treatment of rare cancer patients in the era of precision oncology: A call to action

2025 · Cancer Treatment Reviews · 2 citations

https://doi.org/10.1016/j.ctrv.2025.103013

Winette T.A. van der Graaf Nina S Heiss C. Hynes S.M. Keller

1210P Neoadjuvant pembrolizumab (pembro) or placebo (pbo) plus chemotherapy and adjuvant pembro or pbo for early stage NSCLC: Subgroup analyses of the phase III KEYNOTE-671 study

2024 · Annals of Oncology · 1 citations

https://doi.org/10.1016/j.annonc.2024.08.1269

M.C. Garassino Shugeng Gao Moïshe Liberman J.D. Spicer

Research topics

topics

Lung Cancer Treatments and Mutations

Lung Cancer Diagnosis and Treatment

Cancer Immunotherapy and Biomarkers

Esophageal Cancer Research and Treatment

Gastric Cancer Management and Outcomes

Chat about Author

Papers

Chat

Click to start Chat